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ABSTRACT
Background: Celiac disease (CD) has a negative impact on the 
health-related quality of life (HRQL) of affected patients. Although 
HRQL and its determinants have been examined in Spanish CD 
patients specifically recruited in hospital settings, these aspects of 
CD have not been assessed among the general Spanish population.
Methods: An observational, cross-sectional study of a non-
randomized, representative sample of adult celiac patients through-
out all of Spain’s Autonomous Regions. Subjects were recruited 
through celiac patient associations. A Spanish version of the self-
administered Celiac Disease-Quality of Life (CD-QOL) question-
naire was used. Determinant factors of HRQL were assessed with 
the aid of multivariate analysis to control for confounding factors.
Results: We analyzed the responses provided by 1,230 
patients, 1,092 (89.2%) of whom were women. The overall mean 
value for the CD-QOL index was 56.3 ± 18.27 points. The dimen-
sion that obtained the most points was dysphoria, with 81.3 ± 
19.56 points, followed by limitations with 52.3 ± 23.43 points; 
health problems, with 51.6 ± 26.08 points, and inadequate treat-
ment, with 36.1 ± 21.18 points. Patient age and sex, along with 
time to diagnosis, and length of time on a gluten-free diet were all 
independent determinant factors of certain dimensions of HRQL: 
women aged 31 to 40 expressed poorer HRQL while time to diag-
nosis and length of time on a gluten-free diet were determinant 
factors for better HRQL scores.
Conclusions: The HRQL level of adult Spanish celiac subjects 
is moderate, improving with the length of time patients remain on 
a gluten-free diet. 
Key words: Celiac disease. Gluten-free diet. Quality of life. Pop-
ulation-based study. Spain.
INTRODUCTION
Celiac disease (CD) is a systemic autoimmune disorder, 
primarily digestive in nature, which is characterized by 
chronic inflammation of the small intestine and due to an 
immune response triggered and maintained by exposure to 
gluten in the diet (1). CD affects both children and adults 
with a genetic predisposition (2,3), but it seems to affect 
women more than men. The overall global prevalence of 
CD is estimated to be 1%, but it varies depending on age 
and country of origin of the study population (4-6). More-
over, the prevalence of the disease is increasing, with much 
higher incidence rates now than 20 years ago (7,8). Fur-
thermore, many researchers acknowledge that the current 
prevalence of the disease may be underestimated due to 
underdiagnosis, especially in adults. 
The prevalence of CD in Spain was calculated in a pop-
ulation-based study which was based on positive blood 
tests (9): this study found that the overall prevalence of CD 
across all age groups was 1:204 subjects, but it was more 
prevalent among children (1:71) than in adults (1:357). 
These numbers have shown no significant variations over 
the past decade (10). The median annual incidence of CD 
among Spanish children was recently estimated to be 7.9 
cases per 1,000 live births and 54 cases per 100,000 peo-
ple/year (11). However, the available population-based 
studies are limited to cases that resulted positive in blood 
tests, which represents only a small proportion of the total 
number of adult celiac patients. Researchers thus empha-
size that Spain may actually have up to 450,000 celiac 
patients, with only 45,000 diagnosed to date (12). 
Patient-reported outcomes (PROs) are increasingly 
important variables in the evaluation of the impact of 
chronic disease. To this end, the most commonly used 
PROs are the subjective constructs based on symptoms and 
patient perception of health-related quality of life (HRQL). 
The impact of PROs on the treatment of chronic disease, 
particularly those related to HRQL, constitutes a topic 
that has generated a high level of interest in the past few 
decades, with improvements to HRQL now comprising a 
specific treatment objective. 
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HRQL is a complex, multidimensional construct 
assessed with the aid of various instruments, usually in the 
form of questionnaires. The generic instruments originally 
used have given way to more specific types of question-
naires for different chronic conditions. In the case of CD, 
Drossman et al. validated the specific CD-QOL question-
naire in 2010 in order to measure HRQL in celiac patients 
(13). This instrument was later adapted and validated for 
use in a Spanish context by Casellas et al. in 2013 (14). 
Several factors contribute to the negative impact that CD 
has on the HRQL of affected patients. The chronic nature 
of CD and the fact that treatment entails a demanding, per-
manent, restrictive diet (15,16) with periodic checkups are 
foremost among them, but other factors include the possibil-
ity of finding other affected family members (17), the lim-
itations that a gluten-free diet imposes on family and social 
activities, and the psychological distress that all these factors 
generate. Indeed, celiac patients present an altered sense of 
well-being (18) due to the symptoms of the disease, the asso-
ciated conditions, and a sense of fatigue (19), among other 
causes. Commencing and following a gluten-free diet has 
repeatedly been demonstrated to improve both the symp-
toms of the disease and HRQL, despite the restrictions this 
type of diet imposes (20,21). The degree of adherence to a 
gluten-free diet has been shown to be an essential factor in 
the HRQL of celiac patients, with better results in patients 
with total adherence (22).
The application of instruments to measure HRQL has 
allowed researchers to make comparisons between different 
stages in the evolution of disease, degrees of affectation, 
and temporal moments in the evolution of patients suffering 
chronic disease. Changes in HRQL are now considered as 
an integral part in the assessment of therapeutic interven-
tions for chronic or prolonged pathologies (23,24). Merely 
having access to health care providers constitutes a factor 
that influences the perception of HRQL reported by patients. 
The majority of studies assessing HRQL in celiac patients 
have been developed within a clinical context and have 
included mostly patients who were recruited in a hospital 
setting. However, the high level of control of CD achieved 
through a strict and permanent gluten-free diet may lead 
patients to lose the perception that they are ill and thus attend 
fewer clinical follow-ups. Moreover, one review has noted 
that long-term follow-up guidelines for celiac patients vary 
widely in their recommendations, many of which are not 
evidence-based (25). For this reason, evaluations of HRQL 
as indicated in the available regulated studies, while accu-
rately reflecting the perception of the level of well-being of 
the subjects to whom they are administered, may not ade-
quately reflect the perception of HRQL among the general 
population of celiac patients, which includes subjects with 
various ranges of adherence to regular follow-up and various 
degrees of access to health care systems.
The goal of this study is to determine the health-related 
quality of life in a representative sample of Spanish adults 
with celiac disease along with its determinant factors. 
METHODS
Study design and area
A cross-sectional, descriptive, observational study of an inten-
tionally non-probabilistic sample of Spanish adults with CD which 
was representative of the national adult celiac population (compris-
ing patients between 16 and 75 years of age) was carried out between 
May and July 2015.
The criteria used to define CD were that the patient had been 
diagnosed by a medical specialist and was affiliated with a regional 
celiac association that was part of the Federation of Celiac Asso-
ciations in Spain (FACE, in its Spanish abbreviation). The need to 
document the diagnosis and to pay association dues was considered 
to indicate a low risk of selection bias. All celiac patients who cor-
rectly filled out the self-administered questionnaire forming the basis 
of this study were included. Subjects under 16 or over 75 years of 
age were excluded from the study.
Study variables 
We designed a data collection notebook that included an expla-
nation of the aims and goals of our study and which guaranteed 
anonymity and confidentiality for all study subjects, along with 
other common ethical concerns. The questionnaire was given to 
the director of every celiac association in each of the 17 autono-
mous communities of Spain. The questionnaire was then forwarded 
to various celiac associations via social media networks, which 
published the questionnaire and requested members to fill it out 
voluntarily. 
The anonymous questionnaire compiled demographic informa-
tion such as age (in completed years) and sex of the study subject 
along with the time from symptoms onset to diagnosis of CD (in 
years), self-reported compliance with a gluten-free diet (yes/no), 
and time living with gluten in the diet (in years).
HRQL was assessed with the aid of a specific CD-QOL ques-
tionnaire, translated into Spanish and validated for use in a Spanish 
setting (14) with adult patients. The CD-QOL consists of 20 items 
examining four dimensions: dysphoria, limitations, health concern, 
and inadequate treatment. The questions are answered by the patient, 
who scores them on a Likert scale from 1 (total disagreement) to 5 
(total agreement). The CD-QOL questionnaire produces an overall 
rating between 0 (worst quality of life) and 100 (best quality of 
life) points. Each of the four dimensions is expressed with the same 
scale of 0-100.
Calculation of the sample size
The number of patients necessary to form an adequate represen-
tation of the Spanish population was calculated taking into consid-
eration the following: the total number of people between 16 and 75 
years of age living in Spain in January 1, 2014 (n = 35, 0111,922) 
(26), an estimated prevalence of CD of 1%, a confidence level of 
95%, and an absolute error of 0.6%. Thus, a minimum of 1,022 
study subjects were needed to develop this study with statistical 
adequacy.
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Statistical analysis
Absolute frequencies were used to express descriptive statistics 
whereas relative frequencies were used for qualitative variables. 
Average values (standard deviation) were used for quantitative 
variables if they presented a normal distribution. Otherwise, medi-
an values (interquartile range) were employed. For the bivariate 
analysis, Pearson’s chi-square test was used when the independent 
and dependent variables were qualitative; if the responding variable 
was quantitative, the Student-Fisher t-test and Analysis of Variance 
(ANOVA) were used. 
Finally, to control for any confounding bias, multivariate analyses 
were carried out with multiple linear regression, where the depen-
dent variable was the rating for the overall quality of life index and 
that of the four dimensions that comprise it, while the independent 
variables were patient sex and age, time to diagnosis, and duration 
of treatment. The SPSS v. 20.0 program was used for all statistical 
analyses. 
Ethical aspects
This observational study was developed based on anonymous 
data and was designed in accordance with the Declaration of Helsin-
ki, as promoted by the World Medical Association (WMA).
RESULTS 
Participants
We included a total of 1,230 celiac patients who filled out 
the questionnaire correctly, including 1,092 ± 89.2% women 
and 138 ± 10.8% men, with an average age of 32.7 ± 10.0 
years (range: 16 to 75 years). No significant differences were 
observed in the distribution of the sample by age, time to diag-
nosis of CD, and time to the start of dietary treatment (impo-
sition of a gluten-free diet) between men and women. Table I 
Table I. Characteristics of the study population overall and by sex
Overall 1,230 Male 133 Female 1,097 p value
Age (years)
 Mean (SD) 32.7 ± 10.41 32.5 ± 10.08 32.7 ± 10.45  0.878*
 Categorized (n/%) (n/%) (n/%)
 16-20 years 129 ± 10.5 17 ± 12.8 112 ± 10.2  0.169**
 21-30 years 443 ± 35.8 39 ± 23.3 401 ± 36.6
 31-40 years 402 ± 32.7 54 ± 40.4 348 ± 31.7
 41-50 years 184 ± 15.0 19 ± 14.3 165 ± 15.0
 51-60 years 61 ± 5.0 3 ± 2.3 58 ± 5.3
 > 60 years 14 ± 1.1 1 ± 0.8 13 ± 1.2
Time to diagnosis (years)
 Mean (SD) 9.2 ± 9.32 10.4 ± 9.70 9.0 ± 9.17  0.222*
(n/%) (n/%) (n/%)
 Up to 1 year 212 ± 17.2 13 ± 9.8 199 ± 18.1  0.153**
 > 1 -5 years 418 ± 34.0 52 ± 39.1 366 ± 33.4
 6-10 years 205 ± 16.7 21 ± 15.8 184 ± 16.8
 11-15 years 128 ± 10.4 14 ± 10.5 114 ± 10.4
 > 15 years 267 ± 21.7 33 ± 24.8 234 ± 21.3
Duration of treatment (years)
 Mean (SD) 8.9 ± 8.94 10.2 ± 9.79 8.7 ± 8.83 0.098*
(n/%) (n/%) (n/%)
 Up to 1 year 224 ± 18.2 13 ± 9.8 211 ± 19.2 0.061**
 > 1 -5 years 421 ± 34.2 51 ± 38.3 370 ± 33.7
 6-10 years 202 ± 16.4 22 ± 16.5 180 ± 16.4
 11-15 years 129 ± 10.5 14 ± 10.6 115 ± 10.5
 > 15 years 254 ± 20.7 33 ± 24.8 221 ± 20.1
*p value obtained with the Student-Fisher t-test; **p value obtained with Pearson’s chi-square test.
184 J. RODRÍGUEZ-ALMAGRO ET AL. Rev esp enfeRm Dig (maDRiD)
Rev esp enfeRm Dig 2016; 108 (4): 181-189
summarizes the principal demographic characteristics of the 
sample population, globally and by sex.
HRQL levels in celiac patients
The average HRQL level in our sample, as assessed with 
the CD-QOL, was 56.3 ± 18.27. Levels were slightly high-
er for men than for women (58.0 vs 56.1, respectively; p = 
0.276). No differences in the overall HRQL ratings were 
observed among the various age groups that comprised our 
sample (Table II).
HRQL levels varied significantly between the different 
dimensions making up the CD-QOL scale, with dysphoria 
being the dimension that obtained the highest mean score 
of 81.3 ± 19.56. This was followed by limitations caused 
by the illness, which had an average rating of 52.3 ± 23.43; 
health problems, with a score of 51.6 ± 26.08; and lastly, 
inadequate treatment, which had the lowest rating, namely 
36.1 ± 21.18 points. The distribution of each dimension is 
represented in figure 1. 
 With regard to individual items, numbers 6, 8, and 9 
(the latter two relating to the perception of having received 
inadequate treatment) obtained the lowest mean scores, as 
shown in table III.
 
HRQL determinants in celiac patients
Patient age and sex, along with time to diagnosis and the 
length of time following a gluten-free diet, were found to 
be the independent factors that determined the HRQL of 
Table II. Univariate results of factors associated with the quality of life of celiac patients and its dimensions
Global score Dysphoria Limitations Health problems Inadequate treatment
Mean score (SD) Mean score (SD) Mean score (SD) Mean score (SD) Mean score (SD)
Sex
 Male 58.0 ± 18.43 83.6 ± 16.80 52.6 ± 23.90 57.9 ± 26.49 30.9 ± 20.73
 Female 56.1 ± 18.25 81.0 ± 19.90 52.3 ± 23.39 50.8 ± 25.94 36.7 ± 21.16
 p value* 0.276 0.103 0.897 0.003 0.003
Age
 16-20 years 59.3 ± 19.79 82.8 ± 18.84 53.5 ± 24.37 60.3 ± 28.91 35.7 ± 23.08
 21-30 years 56.4 ± 17.55 81.7 ± 18.15 51.8 ± 22.74 52.1 ± 26.46 36.7 ± 20.70
 31-40 years 54.8 ± 18.08 81.2 ± 20.27 51.2 ± 23.74 48.0 ± 24.73 35.2 ± 19.84
 41-50 years 56.5 ± 17.70 80.6 ± 19.90 53.8 ± 22.19 50.9 ± 23.98 35.0 ± 22.51
 51-60 years 57.6 ± 21.58 77.3 ± 24.95 56.7 ± 26.75 53.7 ± 27.46 41.8 ± 24.78
 > 60 años 62.8 ± 21.05 83.5 ± 18.12 61.9 ± 27.55 58.9 ± 26.76 34.8 ± 19.72
 p value** 0.144 0.557 0.409 < 0.001 0.298
Time to diagnosis**
 Up to 1 year 51.8 ± 18.73 72.8 ± 22.14 46.2 ± 22.89 50.2 ± 25.85 39.3 ± 19.97
 > 1 -5 years 52.8 ± 17.39 78.0 ± 20.77 48.1 ± 22.52 48.2 ± 24.51 34.4 ± 21.66
 6-10 years 56.5 ± 16.50 84.0 ± 17.08 51.2 ± 22.25 51.8 ± 24.33 36.5 ± 20.46
 11-15 years 60.4 ± 18.29 86.6 ± 17.83 58.5 ± 22.48 54.5 ± 27.72 31.3 ± 22.02
 > 15 years 63.4 ± 18.08 88.6 ± 14.55 61.7 ± 23.10 56.4 ± 28.34 38.0 ± 21.01
 p value** < 0.001 < 0.001 < 0.001 0.001 0.003
Treatment duration
 Up to 1 year 51.3 ± 18.75 71.9 ± 22.76 46.2 ± 23.00 48.7 ± 25.96 39.3 ± 19.57
 > 1 -5 years 53.0 ± 17.11 78.4 ± 19.62 48.1 ± 22.14 48.5 ± 24.38 35.5 ± 22.30
 6-10 years 56.6 ± 16.87 84.1 ± 17.17 51.3 ± 22.50 55.5 ± 24.43 35.8 ± 20.13
 11-15 years 60.4 ± 18.23 86.5 ± 17.81 58.3 ± 22.60 55.0 ± 27.66 30.9 ± 21.14
 > 15 years 64.0 ± 18.00 89.5 ± 13.74 62.5 ± 23.26 56.7 ± 28.37 37.1 ± 21.07
 p value** < 0.001 < 0.001 < 0.001 < 0.001 0.009
*p value obtained with the Student-Fisher t-test* and Analysis of Variance (ANOVA)**.
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adult patients with CD, as assessed with both univariate 
and multivariate analyses. However, each of these factors 
had a differential influence on the various dimensions 
included in the CD-QOL questionnaire (Table IV).
Women rated the dimension health problems lower than 
men (50.8 vs. 57.9, respectively; p = 0.03), while they gave 
the dimension of inadequate treatment a higher score than 
men did (36.7 vs. 30.9; p = 0.003) (Table II); this latter 
association was likewise documented in the multivariate 
analysis (Table IV). For the remaining dimensions, no gen-
der differences were observed. 
Age was associated with a lower score in the health 
problems dimension, which was rated significantly lower 
by patients between 31 and 40 years of age, as determined 
through univariate analysis (Table II). The multivariate 
analysis revealed an association between an advanced 
patient age and a lower rating for this dimension (Table 
IV). 
The amount of time it took until an accurate diagnosis 
of CD was made significantly affected the ratings of all 
dimensions of the CD-QOL index (Table II); however, the 
multivariate analysis only showed a significant association 
for the inadequate treatment dimension, in the sense that 
the greater the amount of time to diagnosis, the worse the 
subjects rated this dimension (Table IV).
Fig. 1. Box plot of the global index of the CD-QOL questionnaire and 
its dimensions.
Table III. Description of scores for items comprising the CD-QOL questionnaire
Number Description Mean (p25-p75)
Item 1 I feel limited by this disease 3 (2-3)
Item 2 I feel worried that I will suffer from this disease 3 (2-4)
Item 3 I feel concerned that this disease will cause other health problems 3 (2-4)
Item 4 I feel worried about my increased risk of cancer from this disease 3 (2-4)
Item 5 I feel socially stigmatized for having this disease 3 (2-4)
Item 6 I feel like I’m limited in eating meals with coworkers 2 (1-3)
Item 7 I feel like I am not able to have special foods like birthday
cake and pizza
3 (2-4)
Item 8 I feel that the diet is sufficient treatment for my disease 2 (1-3)
Item 9 I feel that there are not enough choices for treatment 2 (1-4)
Item 10 I feel depressed because of my disease 5 (4-5)
Item 11 I feel frightened by having this disease 5 (4-5)
Item 12 I feel like I don’t know enough about the disease 4 (3-5)
Item 13 I feel overwhelmed about having this disease 5 (4-5)
Item 14 I have trouble socializing because of my disease 4 (3-5)
Item 15 I find it difficult to travel or take long trips because of my disease 3 (2-4)
Item 16 I feel like I cannot live a normal life because of my disease 4 (3-5)
Item 17 I feel afraid to eat out because my food may be contaminated 3 (1-4)
Item 18 I feel worried about the increased risk of one of my family
members having coeliac disease
3 (2-4)
Item 19 I feel like I think about food all the time 3 (2-5)
Item 20 I feel concerned that my long-term health will be affected 3 (2-4)
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Lastly, a significant association was observed between 
the length of time patients had followed a gluten-free diet 
and the mean rating for HRQL on the CD-QOL scale over-
all and in each of its four dimensions (Table II). This sig-
nificant association was maintained after the multivariate 
analysis, both for the overall index as well as in three of 
the four dimensions (Table IV). A longer period on a glu-
ten-free diet was associated with a higher overall rating 
on the CD-QOL scale and in the dysphoria and limitations 
dimensions. The inadequate treatment dimension showed 
a significant inverse relation. 
DISCUSSION
This study evaluates the HRQL of a representative sam-
ple of Spanish adults with CD, both globally and among its 
various dimensions, in order to determine the factors that 
are determinant or associated with it. What differentiates 
this study from previous research is that it is the first study 
conducted using a CD-QOL questionnaire (14) that had 
been linguistically and culturally adapted and validated for 
use in a Spanish context, specifically for adults with CD. 
The main result of this study is that our series of adult 
Spanish celiac subjects, representative of the general celi-
ac population, expressed a mean HRQL of 56.3 (out of 
a maximum of 100 points), notably lower than the rat-
ings observed in the scant number of prior studies which 
used the same instrument (the CD-QOL questionnaire) in 
a Spanish setting. Thus, the quality of life levels reported 
by patients recruited in Spanish hospitals ranged from 80 
points for patients who strictly followed a gluten-free diet 
to 70 points for patients who did not follow a gluten-free 
diet (either unknowingly or intentionally) (22), while new-
ly diagnosed cases and patients who had followed a glu-
ten-free diet for longer than a year showed overall mean 
HRQL ratings of 72-73 points (14). Studies based on the 
same instrument but used in other sociocultural contexts 
are rare, mostly because the original CD-QOL question-
naire was only validated in 2010. One study conducted 
on celiac patients in an area of New York (USA) which 
used the CD-QOL questionnaire found quality of life 
levels higher than those documented in our study (27), 
but other studies based on more generic instruments (e. 
g., the EuroQOL) (28) found lower HRQL levels in celi-
ac patients than those observed in the New York series 
(29,30). Our results suggest that the HRQL found in the 
general population of adult celiac subjects may be lower 
than that observed in patients recruited in a hospital set-
ting, giving rise to the hypothesis that periodic medical 
check-ups improve the quality in life for these patients by 
encouraging a stricter compliance with a gluten-free diet. 
In fact, the correct maintenance of a gluten-free diet has 
repeatedly been shown to be an independent factor associ-
ated with a better quality of life among celiac patients, both 
in children (31) and adults (19,20,22,32,33). Our study did 
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not examine the adherence to medical follow-up among the 
study subjects; therefore, further studies must be made to 
provide solid data to support this hypothesis. 
In our study, patient gender was shown to be an inde-
pendent factor associated with the perception of HRQL 
in CD, one that has a significant effect on both the health 
problems and inadequate treatment dimensions of the 
CD-QOL questionnaire, with women giving an average 
rating 6.69 points lower than men in the former dimension 
and 5.64 points higher in the latter. One speculative expla-
nation for this may be the greater difficulty perceived by 
the Spanish men in our series in finding substitutions or 
alternatives for foods when following a gluten-free diet in 
comparison to women, or the greater value placed on the 
act of eating on the part of men. In the Spanish context, 
women generally bear greater responsibility for buying and 
preparing food, perhaps conditioning a greater dependence 
on the part of men in this respect. We feel that the ratio of 
men to women in our series (1:9) does not affect this result, 
as it was controlled for by univariate and multivariate anal-
yses. At any rate, it should be noted that the disproportion-
ate numbers of men and women in our sample do not in 
any way reflect the distribution of men and women in the 
adult celiac population in Spain, but rather a different rate 
of response to a voluntary questionnaire among the sexes. 
In fact, all the epidemiological studies carried out to date 
have repeatedly documented the overall predominance of 
CD among women, with a female:male ratio varying from 
2.5:1 to 3:1 (34). In cases of adult onset CD, the frequency 
among women may be even greater; prior studies of CD 
in Spain with somewhat different data have estimated the 
proportional frequency to be between 3:1 and 4:1 (35,36) 
and up to 9:1 among adult patients newly diagnosed with 
CD (37).
The lowest scores on the CD-QOL questionnaire were 
for items directly related to diet, namely items 6, 8, and 9. 
The first of these, item 6 (“It affects me that I’m limited as 
to what I can eat with my friends”), refers directly to the 
negative social repercussions arising from a gluten-free 
diet whereas the other two items with low scores denote 
concepts which appear to contradict each other, namely 
item 8 (“I feel that dietary treatment is sufficient for my 
illness”) and item 9 (“I feel like there are not enough treat-
ment options available”). While dietary treatment is con-
sidered to be a sufficient therapeutic intervention for curing 
CD, patients simultaneously recognize that it is difficult to 
comply with a strict, gluten-free diet and they would like to 
have more treatment options, perhaps including a broader 
variety of dietetic options directed at greater standardiza-
tion towards a non-restricted diet.
The celiac patients in our series also expressed anxi-
ety about the possibility of developing cancer (item 4: “I 
am worried about having a higher risk of cancer due to 
my illness”), with an average score of 3 out of 5 points, 
in direct contrast with the fact that CD is not specifically 
associated with a higher risk of cancer (38). Indeed, the 
type of tumor for which CD patients present an increased 
risk, intestinal lymphoma (39), is not only quite rare, but 
also becomes less likely in patients following a gluten-free 
diet to the point that they present no higher risk for this 
type of cancer than the general population. In contrast, 
CD actually represents a protective factor against several 
other types of neoplasms, such as breast and endometrial 
tumors (39). The perceived risk of certain comorbidities 
commonly associated with CD, such as osteoporosis and 
its clinical manifestation as bone fractures (40,41), was not 
observed in our sample.
Of the four dimensions that make up the CD-QOL, 
dysphoria received the highest scores in our series of CD 
patients, followed by health problems. Inadequate treat-
ment was the dimension which received the lowest mean 
score. This is in agreement with previous studies conduct-
ed with Spanish celiac subjects (14,22). One new finding 
from our study is that HRQL (expressed as the overall 
CD-QOL index as well as in two of its dimensions, dyspho-
ria and limitations) increased in accordance with the length 
of time that patients followed a gluten-free diet. Only the 
dimension inadequate treatment showed an inverse rela-
tionship between duration of treatment and HRQL. This 
result is in agreement with that found in a previous Spanish 
study conducted by Casellas et al. (22), the results of which 
complement our findings, namely that in addition to the 
degree of compliance (patients who strictly complied with 
a gluten-free diet expressed a better quality of life than 
those that did not fully comply, either knowingly or inad-
vertently), the longer celiac patients followed a gluten-free 
diet, the higher they rated their quality of life.
The strength of our study comes from its ample sample 
size (1,230 subjects), the representative nature of the sam-
ple with regard to celiac population in Spain as a whole, 
and the controlling for possible confounders by means of 
multivariate analysis. Together, these aspects make our 
study an accurate assessment of HRQL of adult celiac 
patients in Spain.
However, our study has several limitations due to the 
absence of a non-randomized sampling protocol. The way 
in which we collected the data, due to the study design 
and the process of working through celiac patient associ-
ations, hindered us from knowing the exact response rates 
and profiles of the patients, who may have received the 
questionnaire and chosen not to respond. The high pro-
portion of females who responded to the survey also may 
affect the representativeness of our research. The attitudes 
of patients who responded voluntarily to treatment may be 
more favorable than those of patients who did not respond; 
thus, participation in this study could reflect either a greater 
involvement on the part of the patient in controlling his 
or her illness (most likely with a stricter compliance with 
a gluten-free diet), or, in contrast, the involvement of the 
most affected patients. 
In conclusion, our study explores for the first time 
the levels of HRQL in a broad sample of Spanish adults 
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with celiac disease, recruited from the general population 
throughout Spain and thus potentially representative of 
the general celiac population on a national level. Overall, 
the perceived HRQL levels were within an average range, 
influenced by patient sex and age along with the time to 
diagnosis and the duration of treatment with a gluten-free 
diet. It is important to note that HRQL increased signifi-
cantly as the longer the patients followed a gluten-free 
diet. Future research should focus on additional determi-
nant factors for the lower overall HRQL of celiac patients 
recruited from the general population with regard to their 
counterparts recruited in a hospital setting. 
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